741 Simultaneous Analysis of Therapeutic Targets CLDN18.2, FGFR2b, CDH17, cMET, HER2, and PD-L1 in Gastric Cancer
Year: 2026
Type: article
Source: Laboratory Investigation
Institutions: CASI Pharmaceuticals (United States), IQ Solutions
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7140077552
